Nalaganje...
Pharmacoproteomics identifies kinase pathways that drive the epithelial-mesenchymal transition and drug resistance in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a complex and deadly disease lacking druggable genetic mutations. The limited efficacy of systemic treatments for advanced HCC implies that predictive biomarkers and drug targets are urgently needed. Most HCC drugs target protein kinases and their kinase-dependent s...
Shranjeno v:
| izdano v: | Cell Syst |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7484106/ https://ncbi.nlm.nih.gov/pubmed/32755597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cels.2020.07.006 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|